Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Karus Therapeutics (United Kingdom)

InstitutionResearch output, impact & collaborations

Karus Therapeutics (United Kingdom) is a research organisation in Didcot, GB. OpenAlex records 86 works and 5,313 citations for it. 32 researchers list it as their most recent affiliation.

86
Works
5,313
Citations
32
Researchers
115
Avg h-index

How has Karus Therapeutics (United Kingdom)'s publication output changed over time?

ScholarIQpublication output · 2015
2
2015

What are the most-cited papers on Karus Therapeutics (United Kingdom)?

ScholarIQmost cited works
Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I
Srđan Verstovšek, Ruben A. Mesa, Jason Gotlib, R. S. Levy, Vikas Gupta, John F. DiPersio, John Catalano, Michael W. Deininger, Carole B. Miller, Richard T. Silver, Moshe Talpaz, E. Winton, Jimmie H. Harvey, Murat O. Arcasoy, Elizabeth O. Hexner, Roger M. Lyons, Azra Raza, Kris Vaddi, William Sun, Wei Peng, V. Sandor, Hagop M. Kantarjian, For the COMFORT-I investigators
S2752781272. 2015331 CitationsOPEN ACCESS
A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis
Alessandro M. Vannucchi, H. Kantarjian, Jean‐Jacques Kiladjian, Jason Gotlib, F. Cervantes, Ruben A. Mesa, Nicholas J. Sarlis, Wei Peng, V. Sandor, P. Gopalakrishna, Abdel Hmissi, Viktoriya Stalbovskaya, Vikas Gupta, Claire Harrison, Srđan Verstovšek, on behalf of the COMFORT Investigators
S2752781272. 2015257 CitationsOPEN ACCESS

How much of the research on Karus Therapeutics (United Kingdom) is open access?

ScholarIQopen access share
100%OPEN ACCESS
Gold
100%
Green
0%
Hybrid
0%
Bronze
0%
Closed
0%

Related on ScholarIQ

Histone Deacetylase Inhibitors Research
Top Topic
Protein Degradation and Inhibitors
Top Topic
PI3K/AKT/mTOR signaling in cancer
Top Topic
Peptidase Inhibition and Analysis
Top Topic
Chronic Lymphocytic Leukemia Research
Top Topic
Animal Disease Management and Epidemiology
Top Topic
470M+ articles · free account